Home/Filings/4/0000950142-17-001796
4//SEC Filing

Roosevelt James Jr. 4

Accession 0000950142-17-001796

CIK 0001145460other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 5:40 PM ET

Size

12.0 KB

Accession

0000950142-17-001796

Insider Transaction Report

Form 4
Period: 2017-10-03
Transactions
  • Disposition to Issuer

    Common Stock

    2017-10-039,9740 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0349,1560 total
    Exercise: $29.55Common Stock (49,156 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-038,0000 total
    Exercise: $22.74Common Stock (8,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0341,6850 total
    Exercise: $33.73Common Stock (41,685 underlying)
Footnotes (2)
  • [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
  • [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.

Issuer

ALERE INC.

CIK 0001145460

Entity typeother

Related Parties

1
  • filerCIK 0001455386

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:40 PM ET
Size
12.0 KB